LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2019

Aug 2, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2019-08-02

Reporting Person: Tessmer James F (VP, Finance & Accounting)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-02	Common Stock	P	10000	$1.14	Acquired	43368	Direct